 | Up a level |
Krenger, Pascal S; Josi, Romano; Sobczak, Jan; Velazquez, Thalia L C; Balke, Ina; Skinner, Murray A; Kramer, Matthias F; Scott, Callum J W; Hewings, Simon; Heath, Matthew D; Zeltins, Andris; Bachmann, Martin F (2024). Influence of antigen density and TLR ligands on preclinical efficacy of a VLP-based vaccine against peanut allergy. Allergy, 79(1), pp. 184-199. Wiley 10.1111/all.15897
Sobczak, Jan M; Krenger, Pascal S; Storni, Federico; Mohsen, Mona O; Balke, Ina; Reseviča, Gunta; Heath, Matthew D; Carreno Velazquez, Thalia L; Kramer, Matthias F; Scott, Callum J W; Skinner, Murray A; Zeltiņš, Andris; Kündig, Thomas M; Vogel, Monique; Bachmann, Martin F (2023). The next generation virus-like particle platform for the treatment of peanut allergy. Allergy, 78(7), pp. 1980-1996. Wiley-Blackwell 10.1111/all.15704
Mohsen, Mona O; Heath, Matthew; Kramer, Matthias F; Velazquez, Thalia Carreno; Bullimore, Alan; Skinner, Murray A; Speiser, Daniel E; Bachmann, Martin F (2022). In situ delivery of nanoparticles formulated with micron-sized crystals protects from murine melanoma. Journal for immunotherapy of cancer, 10(9) BioMed Central 10.1136/jitc-2022-004643
Heath, Matthew D; Mohsen, Mona O; de Kam, Pieter-Jan; Carreno Velazquez, Thalia L; Hewings, Simon J; Kramer, Matthias F; Kündig, Thomas M; Bachmann, Martin F; Skinner, Murray A (2020). Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT®). Frontiers in immunology, 11, p. 594911. Frontiers Research Foundation 10.3389/fimmu.2020.594911
Storni, Federico; Zeltins, Andris; Balke, Ina; Heath, Matthew D; Kramer, Matthias F; Skinner, Murray A; Zha, Lisha; Rösti, Elisa; Engeroff, Paul; Muri, Lukas; von Werdt, Diego; Gruber, Thomas; Cragg, Mark; Mlynarczyk, Margrit; Kündig, Thomas M; Vogel, Monique; Bachmann, Martin (2020). Vaccine against peanut allergy based on engineered Virus-Like-Particles displaying single major peanut allergens. Journal of allergy and clinical immunology, 145(4), 1240-1253.e3. Elsevier 10.1016/j.jaci.2019.12.007
Bachmann, Martin F.; Mohsen, Mona O.; Kramer, Matthias F; Heath, Matthew D (2020). Vaccination against Allergy: A Paradigm Shift? Trends in molecular medicine, 26(4), pp. 357-368. Cell Press 10.1016/j.molmed.2020.01.007
Cabral-Miranda, Gustavo; Lim, Stephanie M; Mohsen, Mona O.; Pobelov, Ilya V.; Rösti, Elisa S.; Heath, Matthew D; Skinner, Murray A; Kramer, Matthias F; Martina, Byron E E; Bachmann, Martin F. (2019). Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection. Vaccines, 7(3), p. 72. MDPI 10.3390/vaccines7030072
Mohsen, Mona O.; Heath, Matthew D; Cabral-Miranda, Gustavo; Lipp, Cyrill; Zeltins, Andris; Sande, Marcos; Stein, Jens V.; Riether, Carsten; Rösti, Elisa; Zha, Lisha; Engeroff, Paul; El-Turabi, Aadil; Kundig, Thomas M; Vogel, Monique; Skinner, Murray A; Speiser, Daniel E; Knuth, Alexander; Kramer, Matthias F; Bachmann, Martin F. (2019). Correction to: Vaccination with nanoparticles combined with micro-adjuvants protects against cancer. Journal for immunotherapy of cancer, 7(1), p. 137. BioMed Central 10.1186/s40425-019-0616-y
Mohsen, Mona O.; Heath, Matthew D; Cabral-Miranda, Gustavo; Lipp, Cyrill; Zeltins, Andris; Sande, Marcos; Stein, Jens V.; Riether, Carsten; Rösti, Elisa; Zha, Lisha; Engeroff, Paul; El-Turabi, Aadil; Kundig, Thomas M; Vogel, Monique; Skinner, Murray A; Speiser, Daniel E; Knuth, Alexander; Kramer, Matthias F; Bachmann, Martin F. (2019). Vaccination with nanoparticles combined with micro-adjuvants protects against cancer. Journal for immunotherapy of cancer, 7(1), p. 114. BioMed Central 10.1186/s40425-019-0587-z
Cabral-Miranda, Gustavo; Heath, Matthew D; Gomes, Ariane C; Mohsen, Mona; Montoya-Diaz, Eduardo; Salman, Ahmed M; Atcheson, Erwan; Skinner, Murray A; Kramer, Matthias F; Reyes-Sandoval, Arturo; Bachmann, Martin (2017). Microcrystalline Tyrosine (MCT®): A Depot Adjuvant in Licensed Allergy Immunotherapy Offers New Opportunities in Malaria. Vaccines, 5(4) MDPI 10.3390/vaccines5040032
